Protalix (PLX) Gets Orphan Drug Recommendation on Taliglucerase Alfa
More News related to PLX
- Protalix Appoints Mr. Zeev Bronfeld Interim Chairman of the Board of Directors
- Protalix BioTherapeutics (PLX) Audit of Carmiel Manufacturing Facility Completed by Israeli Ministry of Health
- Protalix Announces Successful GMP Manufacturing Audit by Israel's Ministry of Health
- Protalix Announces Successful GMP Manufacturing Audit by Israel's Ministry of Health
- Protalix BioTherapeutics (PLX) Moves Up on Biotech "Takeover Fever"
More News related to Corporate News
- Trichet Comments On Greece, Inflation, the Euro vs Dollar and EMF
- Janet Yellen Expected To Be Tapped as Federal Reserve Vice Chairman
- Pre-Market Indices - DJIA Up 34, NASDAQ Up 4.75, S&P 500 Up 4.75
Protalix (NYSE: PLX) gets recommendation for orphan drug on taliglucerase alfa
Related Categories
Corporate NewsFDA
Hot List
Stocks Mentioned
-0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
